Mayne Pharma set to defer capital return to investors
MELBOURNE: Mayne Pharma will defer a $65.5m capital return to shareholders by at least two
MELBOURNE: Mayne Pharma will defer a $65.5m capital return to shareholders by at least two
FEATURED
Major assisted-living investor acquires $78.6m senior housing complex
Digital tools boost dementia care for homebound patients
Developer proposes turning empty offices into seniors housing
Architects designs stepped senior housing to “balance togetherness with independence”
Tropical oasis offers sanctuary from the troubles of ageing
Affordable housing group open 81-unit seniors housing community
INNOVATION
